1. Home
  2. RMCO vs UBX Comparison

RMCO vs UBX Comparison

Compare RMCO & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMCO
  • UBX
  • Stock Information
  • Founded
  • RMCO 2021
  • UBX 2009
  • Country
  • RMCO United States
  • UBX United States
  • Employees
  • RMCO N/A
  • UBX N/A
  • Industry
  • RMCO Multi-Sector Companies
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RMCO Miscellaneous
  • UBX Health Care
  • Exchange
  • RMCO Nasdaq
  • UBX Nasdaq
  • Market Cap
  • RMCO 14.9M
  • UBX 16.5M
  • IPO Year
  • RMCO N/A
  • UBX 2018
  • Fundamental
  • Price
  • RMCO $1.08
  • UBX $1.73
  • Analyst Decision
  • RMCO
  • UBX Strong Buy
  • Analyst Count
  • RMCO 0
  • UBX 2
  • Target Price
  • RMCO N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • RMCO 44.3K
  • UBX 303.9K
  • Earning Date
  • RMCO 01-31-2025
  • UBX 11-04-2024
  • Dividend Yield
  • RMCO N/A
  • UBX N/A
  • EPS Growth
  • RMCO N/A
  • UBX N/A
  • EPS
  • RMCO N/A
  • UBX N/A
  • Revenue
  • RMCO $695,792.00
  • UBX N/A
  • Revenue This Year
  • RMCO N/A
  • UBX N/A
  • Revenue Next Year
  • RMCO N/A
  • UBX $33.62
  • P/E Ratio
  • RMCO N/A
  • UBX N/A
  • Revenue Growth
  • RMCO 46.15
  • UBX N/A
  • 52 Week Low
  • RMCO $0.70
  • UBX $0.94
  • 52 Week High
  • RMCO $1.80
  • UBX $2.02
  • Technical
  • Relative Strength Index (RSI)
  • RMCO 55.01
  • UBX 63.32
  • Support Level
  • RMCO $0.96
  • UBX $1.56
  • Resistance Level
  • RMCO $1.04
  • UBX $1.85
  • Average True Range (ATR)
  • RMCO 0.07
  • UBX 0.22
  • MACD
  • RMCO 0.00
  • UBX 0.05
  • Stochastic Oscillator
  • RMCO 89.30
  • UBX 75.96

About RMCO Royalty Management Holding Corporation

Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: